TrialBlood2020
Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
Mikko Myllymäki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this papertrialcites it